8 Biotech Stocks So Cheap That Their Technology Is Effectively Free

Text size A number of biotechs have market values that are less than the cash on their balance sheets. Dreamstime It’s mid-February, and the beleaguered biotech sector is showing no real signs of reco...

Teladoc Stock Has Tumbled. Goldman Sachs Sees a Major Recovery.

Text size Teladoc stock is set for a big comeback, says Goldman Sachs. Courtesy of Teladoc Teladoc Health stock has shed half its value in the past six months. An analyst at Goldman Sachs says it’s ti...

Aurora Cannabis stock gains after first beat on pot sales in more than a year

Aurora Cannabis Inc. shares gained in late trading Thursday, after the Canadian pot producer beat sales expectations for the first time in more than a year. Aurora ACB, -1.08% ACB, -1.02% reported a f...

Pfizer Stock Is Falling. Did Investors Misunderstand the Revenue Guidance?

Pfizer CEO Albert Bourla talks. John Thys/Pool/AFP/Getty Images Text size Pfizer shares dropped sharply after the company’s 2022 sales guidance appeared to fall short of expectations. The guidance tha...

CVS Stock Is Tumbling. Lowered Range for Cash-Flow Guidance Unnerved Investors.

Text size CVS stock is falling after earnings. Bryan Bedder/Getty Images for CVS Pharmacy   CVS Health stock was falling after lowered cash-flow guidance overshadowed better-than-expected fourth-quart...

Enphase Energy Stock Jumps. It Has Solved the Solar Supply-Chain Problem.

Text size A general view of solar modules Feng Li/Getty Images Enphase Energy shares were rising sharply Wednesday after the solar energy company’s quarterly earnings and first-quarter guidance barrel...

Enphase Energy’s Earnings and Guidance Top Estimates. The Stock Is Soaring.

Text size A general view of solar modules Feng Li/Getty Images Enphase Energy shares were soaring Wednesday after the solar energy company’s quarterly earnings and first-quarter guidance barreled past...

Pfizer Stock Fell 2.8%. Did Investors Misunderstand the Revenue Guidance?

Text size Pfizer CEO Albert Bourla talks. John Thys/Pool/AFP/Getty Images Pfizer shares dropped sharply on Tuesday after the company’s 2022 sales guidance appeared to fall short of expectations. The g...

Novavax Stock Tumbles on Report That Vaccine Deliveries Are Lagging

Text size Novavax labs in Gaithersburg, Md. Andrew Caballero-Reynolds/AFP via Getty Images Novavax shares were plunging more than 15% Tuesday after the company acknowledged to Reuters that it has comp...

Pfizer Reports Earnings Tuesday. What to Expect.

Text size Pfizer is scheduled to report its earnings before the market opens on Tuesday. Jeenah Moon/Getty Images There’s no mystery about what 2022 will bring for Pfizer : Enormous, record-shattering...

Disney, Chipotle, Pfizer, Twitter, Coca-Cola, and Other Stocks for Investors to Watch This Week

Text size Uncredited We’re past the peak of fourth-quarter earnings season, but still with many notable companies left to report. Some 75 S&P 500 components are scheduled for this week. Tyson Food...

6 Stocks to Play the New U.S. Economic Reopening

UPS was a Covid beneficiary—until it wasn’t. Now, it again looks like a reopening play. Mario Tama/Getty Images Text size Covid cases are falling and the economy is about to reopen—again. Playing it, ...

Bears beware. Past corrections for the S&P 500 are only 15% on average, outside of recessions

Even after a rough January for Wall Street, it might take the U.S. economy slipping into a recession before the S&P 500 index risks entering a bear market, according to Oxford Economics. “Equities...

Opinion: AT&T and 4 more unloved dividend stocks to buy in a ‘risk-off’ era

With stocks off to one of their worst starts to the year since the 2008-2009 financial crisis, it’s no longer crazy to talk about a sustained period of market volatility or a prolonged “risk off” envi...

The Worst Big IPOs of 2021

Text size Oscar Health shares closed at $6.20 on Friday, down 84% from the IPO price. Gabby Jones/Bloomberg IPOs soared for most of 2021, making the year one of the best ever for companies to list the...

U.S. Stock Futures Poised for Lower Open on Monday

Stocks are poised to open lower on Monday. Michael Nagle/Bloomberg Text size Here’s what you need to know to navigate the markets today. • U.S. stocks are set to open Monday slightly down. On Sunday n...

What CEOs Are Saying About Inflation: ‘The World Has Changed’

This is what some of the world’s corporate leaders said on their quarterly earnings calls this week about what they are seeing and doing about inflation. “We’re seeing inflation.…Logistics, as I’ve me...

Moderna Faces Challenges Beyond the Covid Vaccine. Its Stock Is Still a Buy for the Long Term.

In 2019, four pharmaceutical giants shared virtually all of the $33 billion worth of vaccine revenue earned worldwide. The pandemic has upended the vaccine business. Moderna has sold or contracted to ...

Investor Bought Up Moderna and Nvidia Stock. It Sold Salesforce and Sirius XM.

Text size A large U.K.-based asset manager bought up Moderna and Nvidia stock in the fourth quarter. Clement Mahoudeau/AFP via Getty Images A large U.K.-based asset manager made big changes in its U.S...

Tech Stocks Got Hit Hard. Where to Find Bargains Now.

The technology sector may not be on sale, but it certainly has gotten cheaper lately. Major technology stocks like Apple (ticker: AAPL), Alphabet (GOOGL), Microsoft (MSFT), and Meta Platforms (FB) are...

Where to Find Bargains Among Tech and Growth Stocks

The technology sector may not be on sale, but it certainly has gotten cheaper lately. Major technology stocks like Apple (ticker: AAPL), Alphabet (GOOGL), Microsoft (MSFT), and Meta Platforms (FB) are...

It’s Time to Bargain Hunt. 27 Picks to Beat the Stock Market From Barron’s Roundtable Experts.

“There is no easier way to make money in the market than to buy a great company under pressure due to short-term concerns.” So said the newest member of the Barron’s Roundtable, David Giroux of T. Row...

Unilever skids after attempt to snag Glaxo’s consumer-health unit, as FTSE 100 climbs

Unilever shares slumped Monday as the consumer products giant suggested it might increase its offer for GlaxoSmithKline’s consumer health unit. Unilever ULVR, -7.02% fell 7% as Glaxo revealed it’s rej...

GlaxoSmithKline shares soar after Unilever bids for its consumer healthcare unit

Shares of GlaxoSmithKline surged on Monday, while Unilever stock tumbled following a failed $68 billion bid by the latter to acquire the pharmaceutical giant’s consumer healthcare arm. Driving the FTS...

Moderna and Novavax Stocks Get Whacked by Supreme Court’s Vaccine Decision

Text size A nurse takes a Moderna Covid-19 vaccines ready to be administered at a vaccination site Apu Gomes/AFP via Getty Images Novavax stock and shares of other vaccine makers fell Friday after the...

These S&P 500 stocks have cratered, but analysts think 12 can turn it around with rebounds of up to 70%

A period of high inflation and rising interest rates has taken out shares of companies with rich valuations. Then there’s the stubborn coronavirus, with variants raising infection rates and causing st...

Biogen’s Alzheimer’s Drug Aduhelm Has Another Shot at Success

Illustration by Elias Stein Text size Biogen ’s Alzheimer’s disease therapy, Aduhelm, has been a disappointment for the company since its Food and Drug Administration approval last spring, with early ...

Deere Goes Autonomous With Its Farmer-Free Tractor

Illustration by Elias Stein Text size One of the biggest themes at this past week’s CES tech show was electric and autonomous transportation—cars, trucks, bikes, boats. And, it turns out, tractors. Fa...

5 Companies That Began 2022 With Upbeat News on Dividends

Royalty Pharma, Life Storage, and Viatris, among other companies, rang in 2022 by announcing dividend increases this week. Royalty Pharma (ticker: RPRX) declared a quarterly dividend of 19 cents a sha...

Not Even GameStop Stock Can Fight the Fed

Text size A Tesla electric vehicle drives through the Las Vegas Convention Center loop at the CES 2022 show this past week. Patrick T. Fallon/AFP/Getty Images The stock market is supposed to be forwar...

Biotech Stocks Are Due to Bounce Back. This One Stands Out.

Text size Large-cap biotech will offer a smoother ride than small, and Vertex, in particular, looks attractive. Igor Akimov/Dreamstime.com Biotech stocks began the year in much the same way they ended...